| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/01/1992 | CA2050049A1 Nor-statine and nor-cyclostatine polypeptides in the treatment of ocular hypertension and glaucoma |
| 03/01/1992 | CA2049883A1 Monoclonal antibody specifically reactive with human perforin |
| 03/01/1992 | CA2048309A1 Method and compositions for inhibiting aminoglycoside nephrotoxicity |
| 02/28/1992 | WO1992003473A1 Cd18 peptide medicaments for the treatment of disease |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | WO1992003145A1 Method of treating viral infection |
| 02/28/1992 | CA2090486A1 Human zona pellucida protein zp3 |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/28/1992 | CA2090427A1 Cd18 peptide medicaments for the treatment of disease |
| 02/28/1992 | CA2090401A1 Method of treating viral infection |
| 02/27/1992 | DE4026964A1 New infectious acid-resistant rhinovirus strain - is e.g. mutant of serotype 14; for treating rhinovirus infection |
| 02/27/1992 | DE4026703A1 New hydroxyethyl-amine and norstatin-type pseudo:peptide(s) |
| 02/26/1992 | EP0472434A2 Antisense oligonucleotides complementary to the macromolecular synthesis operon of bacteria, and their uses in diagnosis and therapy |
| 02/26/1992 | EP0472399A2 HLA-DR antigen gene, its nucleotide sequence and its use |
| 02/26/1992 | EP0472220A1 Bradykinin antagonists |
| 02/26/1992 | EP0472078A2 Phosphonopyrrolidin- and piperidin-containing statin-type pseudopeptides, their preparation and use against retroviruses |
| 02/26/1992 | EP0472077A2 Phosphonate containing hydroxyethylamin- and norstatin-type pseudopeptides |
| 02/26/1992 | EP0472011A1 Composition containing protease produced by vibrio and method of use in debridement and wound healing |
| 02/26/1992 | EP0471825A1 PTPase DIAGNOSTICS AND USES THEREOF |
| 02/26/1992 | EP0471804A1 Novel human cyclin a compositions and their production method, a corresponding nucleotide sequence, a method and agents for detecting or diagnosing cell multiplication, and a method and agents for inhibiting cell multiplication |
| 02/26/1992 | EP0471796A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| 02/26/1992 | EP0471793A1 Improved forms of basic fibroblast growth factor |
| 02/26/1992 | EP0471787A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor |
| 02/26/1992 | EP0471778A1 Herpes simplex virus type 2-glycoprotein g proteins and polypeptides |
| 02/26/1992 | EP0471759A1 HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI) |
| 02/26/1992 | EP0471752A1 Polypeptides of feline t-cell lymphotropic lentivirus |
| 02/26/1992 | EP0218712B1 Novel procoagulant proteins |
| 02/26/1992 | CN1058990A Protein structure of plant toxin gelonin |
| 02/25/1992 | US5091575 Peptidylaminodiols |
| 02/25/1992 | US5091542 Trivalent coupling agents for linking fab fragments to form bifunctional and trifunctional antibody-like compounds |
| 02/25/1992 | US5091512 Fibrinogen-specific monoclonal antibody |
| 02/25/1992 | US5091511 Lymphokine activated killer suppressive factor (LAKSF), process for producing it and immunosuppressive agent comprising it |
| 02/25/1992 | US5091510 Retro-inverso analogues of thymopentin, and their use in the preparation of pharmaceutical compositions |
| 02/25/1992 | US5091375 Nikkomycin derivatives |
| 02/25/1992 | US5091368 Biologically active compounds from blue-green algae |
| 02/25/1992 | US5091367 Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 02/25/1992 | US5091366 Natriuretics, hypotensive agents |
| 02/25/1992 | US5091365 Cyclic peptides as promoters of absorption on administration onto the mucosa |
| 02/25/1992 | US5091364 Preparation of immunologically active cell wall components from archaebacteria |
| 02/25/1992 | US5091363 Mixture of Factor viii, antitnrombin, phospholipid, calcium! compound, and factor ix |
| 02/25/1992 | US5091313 Antigenic epitopes of IgE present on B cell but not basophil surface |
| 02/25/1992 | US5091302 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof |
| 02/25/1992 | US5091193 Zinc oxide, phytic acid and an ester of a fatty alcohol as anti-enzyme |
| 02/25/1992 | US5091188 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 02/25/1992 | US5091185 Growth hormones with release inhibiting coating of hydrolysed polyvinyl alcohol |
| 02/25/1992 | US5091180 Protection against rhabdomyolysis-induced nephrotoxicity |
| 02/25/1992 | US5091178 Tumor therapy with biologically active anti-tumor antibodies |
| 02/25/1992 | US5091173 Hair growth composition |
| 02/25/1992 | CA2049743A1 Bradykinin antagonists |
| 02/25/1992 | CA2049645A1 Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type |
| 02/25/1992 | CA1296486C Therapeutic peptides |
| 02/25/1992 | CA1296273C Recombinant methods for production of serine protease inhibitors and methods for isolation of same |
| 02/25/1992 | CA1296272C Superoxide dismutase cloning and expression in microorganisms |
| 02/25/1992 | CA1296253C Stabilized growth hormone compositions |
| 02/25/1992 | CA1296252C Method and composition for prophylaxis and treatment of viral infections |
| 02/24/1992 | CA2049538A1 Chondromodulin-i protein |
| 02/24/1992 | CA2049497A1 Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses |
| 02/21/1992 | CA2049401A1 Heparin binding neurotrophic factor gene sequence |
| 02/21/1992 | CA2049370A1 Human mk gene and protein sequence |
| 02/20/1992 | WO1992002626A1 Eliminating internal initiation of soluble cd4 gene |
| 02/20/1992 | WO1992002625A1 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax |
| 02/20/1992 | WO1992002624A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
| 02/20/1992 | WO1992002623A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 02/20/1992 | WO1992002620A1 Chimeric neurotrophic factors |
| 02/20/1992 | WO1992002612A2 Tissue plasminogen activator variants with decreased clearance |
| 02/20/1992 | WO1992002556A1 Human colon cancer cell-derived fibroblast elongation factor |
| 02/20/1992 | WO1992002555A1 A fibronectin binding peptide |
| 02/20/1992 | WO1992002554A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/20/1992 | WO1992002553A1 Tumor cell binding molecule with protease inhibiting region |
| 02/20/1992 | WO1992002552A1 Granulocyte-inhibiting polypeptide |
| 02/20/1992 | WO1992002546A1 Synthetic peptides that antagonize neurokinin a, their salts and their manufacturing processes |
| 02/20/1992 | WO1992002544A1 Peptides of the chromostatin family |
| 02/20/1992 | WO1992002543A1 Novel immunosuppressant peptides |
| 02/20/1992 | WO1992002541A1 Biologically active compounds from blue-green algae |
| 02/20/1992 | WO1992002539A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/20/1992 | WO1992002538A1 Product and method for transfer of colostrum-derived disease preventing constituents across the gastrointestinal tract |
| 02/20/1992 | WO1992002248A1 Tachykinin agonists for treatment of alzheimer's disease |
| 02/20/1992 | WO1992002247A1 Method for treating corneal endothelial wounds |
| 02/20/1992 | WO1992002246A1 Growth factor compositions, preparation and use |
| 02/20/1992 | WO1992002242A1 Use of metalloporphyrins to potentiate aids therapy |
| 02/20/1992 | WO1992002238A1 Tissue bonding and sealing composition and method of using the same |
| 02/20/1992 | WO1992002237A1 Analogs of endothelin |
| 02/20/1992 | WO1992002236A1 Agent for preventing and treating hepatitis |
| 02/20/1992 | WO1992002230A1 Pharmaceutical composition containing one or more bleomycins, and one or more proteins inactivating said bleomycins |
| 02/20/1992 | WO1992002229A1 Immunosuppressive compositions |
| 02/20/1992 | WO1992002133A1 Improved diagnostic and therapeutic compositions |
| 02/20/1992 | WO1991019743A3 Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | WO1991019734A3 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 02/20/1992 | DE4026146A1 Compsn. for treating osteoporosis without affecting calcium balance - contains central region of parathormone and biologically active vitamin=D metabolite |
| 02/20/1992 | CA2088990A1 Chimeric neurotrophic factors |
| 02/20/1992 | CA2088593A1 Use of metalloporphyrins to potentiate aids therapy |
| 02/20/1992 | CA2088492A1 Immunosuppressive compositions |
| 02/20/1992 | CA2088164A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/19/1992 | EP0471660A2 Protein C for treating pain |
| 02/19/1992 | EP0471651A2 Peptide boronic acid derivatives having protease inhibiting activity |
| 02/19/1992 | EP0471618A1 Calcitonin-containing emulsion for nasal administration |
| 02/19/1992 | EP0471549A2 Lipoprotein removal by soluble enzymes |
| 02/19/1992 | EP0471453A2 Cyclic HIV principal neutralizing determinant peptides |
| 02/19/1992 | EP0471280A2 Trans-2-acylaminocyclohexyloxyacyldipeptides |